Envoy Medical Secures Three Patents for Processing, Integration and Diagnostics
Envoy Medical received U.S. Patent No. 12,544,564 on February 10 for a cochlear implant system with improved input signal-to-noise ratio and two Hong Kong patents—HK40102155 for hearing aid integration and HK40107235 for electrode impedance diagnostics. These patents bolster its IP ahead of potential PMA submission for the Acclaim CI device.
1. Patent Issuance
On February 10, U.S. Patent No. 12,544,564 was granted for a cochlear implant system featuring improved input signal-to-noise ratio. Hong Kong Patent Nos. HK40102155 and HK40107235 cover hearing aid integration and electrode impedance diagnostics, respectively.
2. Strategic Implications
The three patents expand Envoy Medical’s intellectual property portfolio in fully implanted hearing devices, reinforcing its first-mover advantage and providing legal protection ahead of potential Premarket Approval submission and commercialization of the Acclaim CI.
3. Product Overview
Envoy Medical’s fully implanted Acclaim cochlear implant is currently under pivotal clinical investigation, while its Esteem fully implanted middle ear implant has been commercially available in the U.S. since 2010, demonstrating the company’s leadership in implantable hearing solutions.